Novel poly(ether urethanes) containing diester groups in the side chains (PU) were synthesized from 4,4Π-diphenylmethyl diisocyanate, polytetramethylene glycol, and diethyl bis(hydroxymethyl)malonate as a chain extender. The surface modification of the PU film was carried out by a hydrolysis reactio
Interaction of heparin with polyallylamine-immobilized surfaces
β Scribed by Ma, Xinghang ;Mohammad, Syed Fazal ;Kim, Sung Wan
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 860 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0021-9304
No coin nor oath required. For personal study only.
β¦ Synopsis
A new method to bind ionically and remove heparin from solution and dilute serum is described. Utilizing cellulose diacetate (CA) as the polymer substrate, a cationic polymer chain-poly(ally1amine)-PALA-was immobilized directly onto the CA surface and onto the surface using poly(ethy1ene glycol) (PEG) spacer groups. The ionic interaction between the anionic heparin molecule and the cationic PALA polymer is specific and effective to remove heparin from the bulk solution. The binding properties of heparin onto the PALA and PEG-PALA surfaces were examined. The effects of PEG spacers on heparin binding onto the PALA-immobilized surface were investigated by varying the M, of PEG spacers. PALA (M, 8500)-immobilized surfaces exhibited enhanced heparin binding. The maximum heparin binding was observed in the region of PEG M, 2000-4000. For the high-molecular-weight PALA (M,,, 50,000)-immobilized surfaces, heparin binding was independent of the molecular weight of PEG. PEG spacers were also evaluated for their ability to prevent or decrease protein (albumin) adsorption. It was observed that at high albumin concentrations, the adsorption of proteins decreased with increasing chain length of PEG, up to M, 3400. These observations suggest that low-molecular-weight PALA (M, 8500)-immobilized CA surfaces with PEG spacers (M, 3400) may provide increased heparin binding capacity and decreased protein adsorption.
π SIMILAR VOLUMES
A covalently bonded conjugate of commercial grade heparin and prostaglandin E l (PGE,) was synthesized to prevent both fibrin formation and platelet aggregation during thrombus formation. The PGE,heparin conjugate was immobilized on an imidazole carbamate derivatized sepharose bead surface through h
Heparin was immobilized onto segmented polyurethane-urea surfaces (Biomer) using hydrophilic poly(ethy1ene oxide) spacers of different chain lengths. The use of the hydrophilic spacer, poly(ethy1ene oxide), reduces protein adsorption and subsequent platelet adhesion on the surface. In addition, the
## Abstract Raman and NMR studies are performed to characterize the solution structures of complexes between heparin and a group of amidated acids, which act as delivery agents that facilitate the gastrointestinal absorption of orally administered heparin. At concentrations typically employed for t
Surfaces of commercial polyurethanes (PUS) were modified by poly(ethy1ene oxide) (PEO) grafting and/or heparin immobilization f o r l o n g -t e r m biomedical applications. PU surfaces were treated with diisocyanate and then reacted with PEO or heparin. The heparin immobilized by various methods on
## Abstract Herein, we report progress toward the development of bioactive surfaces based on Ξ³βaminobutyric acid (GABA), a major neurotransmitter in the nervous system. Whereas immobilization techniques have focused largely on antibodies, enzymes, and receptors, to our knowledge, this is the first